CompletedNot Applicable

Etude PROTECT : Prognostic Role of Tapse Evaluation in Children's bronchioliTis

France46 participantsStarted 2022-10-18

Plain-language summary

In this prospective study, we aim to evaluate the association between an echocardiographic marker of right ventricular systolic function, the TAPSE (Tricuspid Annular Plane Systolic Excursion), and poor outcome in patients admitted to Pediatric Intensive Care Unit (PICU) for Acute Bronchiolitis (AB).

Who can participate

Age range0 Months – 2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infants under the age of 2 * Admitted to PICU with diagnosis of acute bronchiolitis (according to AAP criteria) * Within the first 36h of PICU stay Exclusion Criteria: * Patients suffering from Chronic Heart Disease, chronic respiratory disease (including bronchopulmonary dysplasia and excluding asthma) * Impairment of echocardiographic window

What they're measuring

PICU lenght of stay

Timeframe: Upon discharge from intensive care, maximum of 5 months

Trial details

NCT IDNCT07209956

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-18

View on ClinicalTrials.gov More Bronchiolitis trials